Mobile Site ›
Print Friendly View

Test ID: PTNT    
Prothrombin G20210A Mutation, Blood

‹ Back to Hematology index

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Useful For Suggests clinical disorders or settings where the test may be helpful

Direct mutation analysis for the prothrombin (PT) G20210A allele should be reserved for patients with clinically suspected thrombophilia. There may be additional indications for direct PT G20210A mutation testing, such as in determining the duration of anticoagulation therapy of venous thromboembolism patients and screening for women contemplating hormone therapy.

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Direct Mutation Analysis

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

Prothrombin G20210A Mutation, B

Aliases Lists additional common names for a test, as an aid in searching

Factor II 20210 mutation
Prothrombin 20210 mutation
Prothrombin Nucleotide
PTNT